Rob Tressler

Rob Tressler

Company: Excellos

Job title: CSO


Excellos 360: Improving cell therapies to drive clinical trial success 1:30 pm

Cell therapy variability has a significant impact on clinical trial outcomes. Part of this variability is due to inconsistent or poorly understood donor starting material. Excellos has developed a deep cell characterization platform that identifies high quality donor starting material with greater potency. The Excellos 360 platform has also been utilized as part of our…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.